Congressional Democrats set the stage for 2019 by raising the stakes on legislation to control drug prices, and Republicans also are pushing bills to rein in drug prices. The drug industry had been fighting off proposals to open drug-pricing practices to public scrutiny, ban tactics to block generic competition and let Medicare negotiate drug prices, and now the industry is facing legislation, a few by potential Democratic presidential candidates, to set up the government as a drug maker, to stop...